Novo Nordisk on Tuesday cut the prices of its diabetes and weight-loss drugs Ozempic and Wegovy by as much as 36% and 48% in India, its second such move, to fend off competition from local drugmakers’ cheaper generics.
Novo Nordisk on Tuesday cut the prices of its diabetes and weight-loss drugs Ozempic and Wegovy by as much as 36% and 48% in India, its second such move, to fend off competition from local drugmakers’ cheaper generics.